111 related articles for article (PubMed ID: 38144256)
1. Shape-Based Virtual Screening of a Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors.
Michino M; Beautrait A; Boyles NA; Nadupalli A; Dementiev A; Sun S; Ginn J; Baxt L; Suto R; Bryk R; Jerome SV; Huggins DJ; Vendome J
ACS Bio Med Chem Au; 2023 Dec; 3(6):507-515. PubMed ID: 38144256
[TBL] [Abstract][Full Text] [Related]
2. Lipoamide channel-binding sulfonamides selectively inhibit mycobacterial lipoamide dehydrogenase.
Bryk R; Arango N; Maksymiuk C; Balakrishnan A; Wu YT; Wong CH; Masquelin T; Hipskind P; Lima CD; Nathan C
Biochemistry; 2013 Dec; 52(51):9375-84. PubMed ID: 24251446
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation.
Saxena S; Renuka J; Yogeeswari P; Sriram D
Mol Inform; 2014 Sep; 33(9):597-609. PubMed ID: 27486079
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Triazaspirodimethoxybenzoyls as selective inhibitors of mycobacterial lipoamide dehydrogenase .
Bryk R; Arango N; Venugopal A; Warren JD; Park YH; Patel MS; Lima CD; Nathan C
Biochemistry; 2010 Mar; 49(8):1616-27. PubMed ID: 20078138
[TBL] [Abstract][Full Text] [Related]
6. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
Saxena S; Devi PB; Soni V; Yogeeswari P; Sriram D
J Mol Graph Model; 2014 Feb; 47():37-43. PubMed ID: 24316937
[TBL] [Abstract][Full Text] [Related]
8. A High-Throughput Assay for Developing Inhibitors of PhoP, a Virulence Factor of Mycobacterium tuberculosis.
Wang L; Xu M; Southall N; Zheng W; Wang S
Comb Chem High Throughput Screen; 2016; 19(10):855-864. PubMed ID: 27748178
[TBL] [Abstract][Full Text] [Related]
9. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
[TBL] [Abstract][Full Text] [Related]
10. Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions.
Ginn J; Jiang X; Sun S; Michino M; Huggins DJ; Mbambo Z; Jansen R; Rhee KY; Arango N; Lima CD; Liverton N; Imaeda T; Okamoto R; Kuroita T; Aso K; Stamford A; Foley M; Meinke PT; Nathan C; Bryk R
ACS Infect Dis; 2021 Feb; 7(2):435-444. PubMed ID: 33527832
[TBL] [Abstract][Full Text] [Related]
11. Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.
Hegymegi-Barakonyi B; Székely R; Varga Z; Kiss R; Borbély G; Németh G; Bánhegyi P; Pató J; Greff Z; Horváth Z; Mészáros G; Marosfalvi J; Erōs D; Szántai-Kis C; Breza N; Garavaglia S; Perozzi S; Rizzi M; Hafenbradl D; Ko M; Av-Gay Y; Klebl BM; Orfi L; Kéri G
Curr Med Chem; 2008; 15(26):2760-70. PubMed ID: 18991635
[TBL] [Abstract][Full Text] [Related]
12. Lead selection and characterization of antitubercular compounds using the Nested Chemical Library.
Sipos A; Pató J; Székely R; Hartkoorn RC; Kékesi L; Őrfi L; Szántai-Kis C; Mikušová K; Svetlíková Z; Korduláková J; Nagaraja V; Godbole AA; Bush N; Collin F; Maxwell A; Cole ST; Kéri G
Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S200-6. PubMed ID: 25801335
[TBL] [Abstract][Full Text] [Related]
13. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds.
Sadybekov AA; Sadybekov AV; Liu Y; Iliopoulos-Tsoutsouvas C; Huang XP; Pickett J; Houser B; Patel N; Tran NK; Tong F; Zvonok N; Jain MK; Savych O; Radchenko DS; Nikas SP; Petasis NA; Moroz YS; Roth BL; Makriyannis A; Katritch V
Nature; 2022 Jan; 601(7893):452-459. PubMed ID: 34912117
[TBL] [Abstract][Full Text] [Related]
14. Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes.
Venugopal A; Bryk R; Shi S; Rhee K; Rath P; Schnappinger D; Ehrt S; Nathan C
Cell Host Microbe; 2011 Jan; 9(1):21-31. PubMed ID: 21238944
[TBL] [Abstract][Full Text] [Related]
15. Exploration of a Large Virtual Chemical Space: Identification of Potent Inhibitors of Lactate Dehydrogenase-A against Pancreatic Cancer.
Sharma H; Sharma P; Urquiza U; Chastain LR; Ihnat MA
J Chem Inf Model; 2023 Feb; 63(3):1028-1043. PubMed ID: 36646658
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
17. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniques.
Sharma K; Neshat N; Sharma S; Giri N; Srivastava A; Almalki F; Saifullah K; Alam MM; Shaquiquzzaman M; Akhter M
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900287. PubMed ID: 31867798
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening Identifies Novel and Potent Inhibitors of
Thongdee P; Hanwarinroj C; Pakamwong B; Kamsri P; Punkvang A; Leanpolchareanchai J; Ketrat S; Saparpakorn P; Hannongbua S; Ariyachaokun K; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Mukamolova GV; Blood RA; Takebayashi Y; Spencer J; Mulholland AJ; Pungpo P
J Chem Inf Model; 2022 Dec; 62(24):6508-6518. PubMed ID: 35994014
[No Abstract] [Full Text] [Related]
20. Homology Modeling of Human Concentrative Nucleoside Transporters (hCNTs) and Validation by Virtual Screening and Experimental Testing to Identify Novel hCNT1 Inhibitors.
Kumar Deokar H; Barch HP; Buolamwini JK
Drug Des; 2017 Mar; 6(1):. PubMed ID: 29167753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
